English eShop Sign in (0 Items) €0.00 Research Areas Applications Products Knowledge Services Company Homepage Company About Sartorius Stedim Biotech Board Board of Directors The Board of Sartorius Stedim Biotech is composed of eight members. The directors are appointed for a three-year period. Joachim Kreuzburg CEO | Chairman Download CV Download Photo Chrystel Baudere Member of the Board Pascale Boissel Member of the Board Susan Dexter Member of the Board René Fáber Member of the Board Anne-Marie Graffin Member of the Board Lothar Kappich Member of the Board Henri Riey Member of the Board Audit Committee Pascale Boissel (Chairwoman) Anne-Marie Graffin Lothar Kappich Henri Riey Remunerations and Nominations Committee Lothar Kappich (Chairman) Susan Dexter Anne-Marie Graffin Henri Riey Better Health for More People Mission and Vision More Information Management Learn More Company Values Learn More Investor Relations Sartorius Stedim Biotech SA Learn More Sign Up for Newsletter General Information Imprint Disclaimer Terms & Conditions Legal Documents Patents and Trademarks Data Protection Cookie Policy Declaration of Consent Company About Sartorius Career Investor Relations Newsroom Sartorius Blogs Exhibition | Conferences Contact © 2021 Sartorius AG

English eShop Research Areas Applications Products Knowledge Services Company Homepage Company About Sartorius Facts & Figures Facts & Figures Sartorius at a Glance Year of foundation 1870 History Number of employees (as Dec 31, 2020) 10,600 Career Global headquarters Göttingen, Germany Sartorius Campus Corporate Structure Legal structure of the Group Sartorius AG is listed on the stock exchange in Frankfurt, Germany. Sartorius manages its business in two legally independent subgroups, Sartorius Stedim Biotech S.A. and Sartorius Lab Holding GmbH. Investor Relations Operating structure of the Group Sartorius conducts its operational business in two divisions: Bioprocess Solutions and Lab Products & Services. Company Global footprint About 60 sites in more than 30 countries, thereof 22 production facilities. Including all sales subsidiaries and commercial agencies presence in more than 110 countries. Corporate Responsibility Financial information Annual sales revenue in 2020 2,336 million euros Online Annual Report 40% - of which EMEA 35% - of which Americas 25% - of which Asia | Pacific 24% - by Division Lab Products & Services 76% - by Division Bioprocess Solutions Underlying EBITDA 692 million euros Underlying EBITDA margin 29.6% Capex ratio 12.3% More Information Company Values Learn More History Learn More Newsroom Learn More Sign Up for Newsletter General Information Imprint Disclaimer Terms & Conditions Legal Documents Patents and Trademarks Data Protection Cookie Policy Declaration of Consent Company About Sartorius Career Investor Relations Newsroom Sartorius Blogs Exhibition | Conferences Contact © 2021 Sartorius AG